Jeffrey S. Ward

Partner
Madison
10 East Doty Street, Suite 600
Madison, WI 53703
D: 608.280.6751
Contact My Assistant
Julie King
D: 608.280.6761

Education

University of Illinois College of Law
J.D., 1984

University of Illinois
B.S. Chemical Engineering, with distinction, 1981

Bar and Court Admissions

State of Wisconsin
State of Illinois
U.S. Supreme Court
U.S. Court of Appeals, Federal Circuit
U.S. Court of Appeals, Seventh Circuit
U.S. District Court, Eastern District of Michigan
U.S. District Court, Northern District of Illinois (including Trial Bar)
U.S. District Court, Western District of Wisconsin
U.S. District Court, Central District of Illinois
U.S. District Court, District of Colorado
U.S. Patent and Trademark Office

Professional Affiliations

American Bar Association

Awards & Recognition

IAM Patent 1000 The World’s Leading Patent Practitioners, 2013-2016
IP Stars by Managing IP, 2013-2015

As a counselor and litigator, Jeff helps his clients navigate the complex patent and regulatory issues related to bringing generic drugs to market. He enjoys developing creative strategies for his clients and then executing those strategies in litigation.

Jeff is a partner in the Madison office. He has concentrated his practice on the representation of generic pharmaceutical companies, including Hatch-Waxman litigation, for more than two decades. His practice focuses primarily in the area of patent litigation, opinion work, and client counseling. Jeff has represented many generic pharmaceutical companies and API manufacturers regarding Abbreviated New Drug Application (ANDA) and 505(b)(2) submissions on a wide variety of products. He has acted as lead counsel and tried numerous Hatch-Waxman litigation matters to verdict.

Jeff has also litigated patent disputes relating to the pharmaceutical, chemical, and mechanical arts in federal courts throughout the United States and in the United States International Trade Commission. Jeff additionally has participated in many patent appeals, including arguing to the U.S. Court of Appeals for the Federal Circuit.

Representative Cases

Sabert Corp. v. Placon Corp., No. 15-cv-182 (W.D. Wis.) (design patent infringement relating to food packaging containers)

Merck Sharp & Dohme v. Xellia Pharmaceuticals, ApS, No. 14-cv-199 (D.Del.) (ANDA for caspofungin for injection)

Pfizer, Inc. et al., v. CFT Pharmaceuticals, LLC, No. 14-cv-781 (D.Del.) (ANDA for tigecycline for injection)

Medicines Company v. Exela Pharma Sciences, LLC et al., No. 14-0058 (W.D.N.C.) (ANDA for bivalirudin for injection)

Sanofi et al. v. Unimark Remedies, Ltd., No. 14-876 (D.Del.) (ANDA for dronedarone tablets)

AbbVie, Inc., et al. v. Hikma Pharmaceutical Co., Ltd., et al., No. 13-cv-1557 (D.Del) (505(b)(2) application for paricalcitol for injection)

Cornerstone Therapeutics et al. v. Exela Pharma Sciences LLC, et al., No. 13-cv-275 (D.Del)(505(b)(2) application for nicardipine for injection)

Novartis Pharmaceutical Corporation v. Pharmaceutics International, et al., No. 12-cv-3967 (D.N.J.) (ANDAs for zoledronic acid for injection)

Novartis Pharmaceutical Corporation v. Hikma Pharmaceutica S.A., et al., No. 12-cv-3967 (D.N.J.) (ANDA for zoledronic acid for injection)

GlaxoSmithKline PLC, et al. v. Hikma Pharm. Co., et al., No. 12-cv-1965 (D.N.J.) (505(b)(2) application for argatroban for injection)

Cadence Pharmaceuticals, Inc. et al. v. Paddock Laboratories LLC. et al., No. 11-CV-733 (D. Del.) (ANDA for acetaminophen I.V.)

Cumberland Pharms. Inc. v. Paddock Labs., LLC, et al., No. 12-cv-619 (D. Del.) (ANDA for acetylcysteine I.V.)

Cumberland Pharms. Inc. v. Perrigo Co., No. 12-cv-6327 (N.D. Ill.) (ANDA for acetylcysteine I.V.)

AstraZeneca Pharmaceuticals et al. v. Aurobindo Pharmaceuticals Ltd. et al., No. 2011-1183 (Fed. Cir. Feb 9, 2012) (ANDA for rosuvastatin calcium)

AstraZeneca Pharmaceuticals et al. v. Aurobindo Pharmaceuticals Ltd. et al., No. 2010-1460 (Fed. Cir.) (ANDA for rosuvastatin calcium)

Novo-Nordisk, Inc. et al. v. Aurobindo Pharma Ltd., No. 12-1388 (Fed. Cir.); No. 12-cv-1-26 (D.N.J.) (ANDA for repaglinide tablets)

Braintree Labs, Inc. v. Paddock Labs., Inc., No. 11-cv-4568 (D.N.J) (ANDA for sodium sulfate/potassium sulfate/magnesium sulfate osmotic laxative preparation)

Allergan et al. v. Watson Laboratories-Florida, Sandoz, Inc., and Paddock Laboratories, Inc., No. 09-511-GMS (Consolidated) (D. Del.) (ANDA for trospium ER capsules)

Purdue Pharmaceuticals et al v. Paddock Laboratories, Inc., No.09-666-KAJ and No. 10-129-KAJ (D. Del.) (ANDA for tramadol ER tablets)

Sanofi-Aventis et al. v. Aurolife Pharma LLC, et al., No. 10-cv-5801 (D.N.J.) (ANDA for fexofenadine tablets)

Takeda Pharm. Co. Ltd., et al. v. Aurobindo Pharma Ltd., et al., No. 10-247 (S.D.N.Y.) (ANDA for pioglitazone tablets) 

In re: Rosuvastatin Calcium Patent Litigation, MDL No. 08-1949 (D. Del.) (ANDA for rosuvastatin calcium tablets)

AstraZeneca Pharmaceuticals LP et al v. Aurobindo Pharma Limited, Inc. et al., No. 07-810 (D. Del.) (ANDA for rosuvastatin calcium tablets)

Future Fibre Technologies Pty. Ltd. v. Optellios, Inc., No. 08-CV-600 (M.D. Fla.) (inventorship dispute regarding laser-based security systems)

Future Fibre Technologies Pty. Ltd. v. Optellios, Inc., No. 09-CV-346 (D. Del.) (inventorship dispute regarding laser-based security systems)

Riezler et al v. Allen et al., No. 08-CV-332 (D. Colo.); No. 09-1528 (Fed. Cir.) (inventorship dispute regarding patents relating to metabolites)

Invitrogen Corporation v. Oxford Biomedical Research, Inc. and Vanderbilt University, No. 08-CV-599 (W.D. Wis.) (patent infringement action)

Z Trim Holdings, Inc. v. Fiberstar, Inc., No. 07-CV-161 (W.D. Wis.) (patent infringement action regarding food additive)

Z Trim Holdings, Inc. v. Fiberstar, Inc., No. 06-CV-361 (W.D. Wis.) (patent infringement action regarding food additive)

Forest Laboratories, Inc. v. Ivax Pharmaceuticals, Inc., et al., 438 F. Supp. 3d 479 (D. Del. 2006) (ANDA for escitalopram tablets)

Medichem S.A. v. Rolabo, S.L., 437 F.3d 1157 (Fed. Cir. 2006) (priority case regarding a process for making a pharmaceutical product)

Eli Lilly & Co. v. Zenith Goldline Pharms., Inc., 364 F. Supp. 2d 820 (S.D. Ind. 2005) (ANDA for olanzapine tablets)

Kraft Foods, Inc. v. Int›l. Trading Co., 203 F.3d 1362 (Fed. Cir. 2000) (patent infringement case regarding food product packaging)

Glaxo, Inc. v. Novopharm Ltd., 931 F. Supp. 1280 (E.D.N.C.1996) (ANDA for ranitidine HCl tablets)

Glaxo, Inc. v. Novopharm Ltd., 52 F.3d 1043 (Fed. Cir. 1995) (ANDA for ranitidine HCl tablets)

Pall Corp. v. Micron Separations, Inc., 66 F.3d 1211 (Fed. Cir. 1995) (patent infringement case regarding membrane filters)

Burroughs Wellcome Co. v. Barr Labs., 40 F.3d 1223 (Fed. Cir. 1994) (ANDA for AZT tablets)

Cardinal Chemical Co. v. Morton Int›l, Inc., 508 U.S. 83 (1993) (patent infringement case regarding chemical additive)


MEDIA CENTER

All Media
Press Releases
10/28/16
Kyle Bass Organization, Merchant & Gould Client, Nabs First Win in Post Grant Review of Gattex® Drug Patent
Merchant & Gould is pleased to announce that its clients, Hayman Capital and the Coalition for Affordable Drugs (CFAD), secured an unprecedented win on Oct. 21, when the Patent Trial and Appeal Board (PTAB) found most claims in U.S. Patent No. 7,056,886 ...
Press Releases
10/17/16
Merchant & Gould Ranked in IAM Patent 1000 - The World's Leading Patent Professionals 2016
Merchant & Gould's patent practice has been recognized in this year's edition of IAM Patent 1000, a publication by Intellectual Asset Management that lists the world’s leading patent professionals. In its 2016 rankings of firms and individuals, ...
Articles
11/14/12
Cumberland Settles 2 Patent Suits Over Generic Acetadote
Please click here to read article. In the Illinois case, Perrigo is represented by Jeffrey S. Ward of M&G and Joseph R. Vallort of Chilton Yambert & Porter LLP.
Articles
4/3/12
Judge Rules Allergan's Sanctura XR Patents Invalid
Press Releases
2/10/12
Merchant & Gould Scores Significant Patent Litigation Victory for Generic Pharmaceutical Manufacturers over AstraZeneca
U.S. Appeals Court Upholds Dismissal of AstraZeneca's Crestor Patent Suits Merchant & Gould, an intellectual property law firm, today announced it has won a litigation victory on behalf of its client Aurobindo Pharma Ltd and other generic pharmaceutical ...
Press Releases
1/21/11
Merchant & Gould Promotes Three Attorneys to Partner
Intellectual property law firm Merchant & Gould is pleased to announce that it has named Jeffrey S. Ward, William D. Schultz and George C. Lewis, P.E. as partners at the firm."These three attorneys consistently demonstrate invaluable experience and ...
Press Releases
3/25/09
Merchant & Gould Announces Plans To Open Madison, WI Office With Four New Lawyers
Additions Will Enhance Firm's Depth in ANDA and other IP Litigation While Building Its Presence in the Western Wisconsin Rocket Docket Merchant & Gould, an intellectual property law firm, today announced that it has added two senior trial attorneys ...